Runway Clinical Intelligence

Executive Business Overview: Runway Clinical Intelligence Inc. Executive Summary Runway Clinical Intelligence Inc. is a specialized clinical underwriting platform and venture creation studio incorporated in Delaware, established to identify, triage, underwrite, and acquire distressed and orphaned clinical-stage therapeutics into dedicated Single-Asset Vehicles (SAVs). Biopharmaceutical drug development represents one of the largest capital allocations in global industry, yet it remains burdened by asymmetric information, volatile financing environments, and rigid corporate development frameworks. Public micro-cap and small-cap biotechnology issuers frequently invest between $30 million and $100 million advancing promising drug candidates through preclinical optimization, IND clearance, Phase 1 dose escalation, and preliminary Phase 2 trials. When macro venture funding contracts, debt markets freeze, or corporate pipelines are restructured around a single lead indication, secondary and tertiary assets with proven biological targets are routinely shelved, defunded, or abandoned. A substantial portion of these programs do not fail due to intractable target biology.